Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Obstetrics & Gynaecology

Clinical Pharmacology

In-utero exposure to metformin for type 2 diabetes or polycystic ovary syndrome: A prospective comparative observational study

Reproductive Toxicology | Jun 07, 2018 Clinical Pharmacology

Lymphocyte immunotherapy for recurrent miscarriages: Predictors of therapeutic success

American Journal of Reproductive Immunology | Jun 07, 2018 Clinical Pharmacology

Socioeconomic status and treatment of depression during pregnancy: A retrospective population-based cohort study in British Columbia, Canada

Archives of Women's Mental Health | Jun 07, 2018 Clinical Pharmacology

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal carcinomatosis: Systematic review of clinical and experimental evidence with special emphasis on ovarian cancer

Archives of Gynecology and Obstetrics | Evidence based | Jun 07, 2018 Clinical Pharmacology

Examining the association of antidepressant prescriptions with first abortion and first childbirth

JAMA Psychiatry | Jun 06, 2018 Clinical Pharmacology

Hormonal, metabolic, and endometrial safety of testosterone vaginal cream vs estrogens for the treatment of vulvovaginal atrophy in postmenopausal women: A randomized, placebo-controlled study

Menopause | Jun 05, 2018 Clinical Pharmacology

A phase II study of frontline paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus, or ixabepilone/carboplatin/bevacizumab in advanced/recurrent endometrial cancer

Gynecologic Oncology | Jun 04, 2018 Clinical Pharmacology

Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol. A secondary analysis from 3 RCTs

American Journal of Obstetrics and Gynecology | Jun 04, 2018 Clinical Pharmacology

Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): A randomised phase 3 trial

The Lancet Oncology | Jun 02, 2018 Clinical Pharmacology

BRCA1/2 mutations and bevacizumab in the neoadjuvant treatment of breast cancer: Response and prognosis results in patients with triple-negative breast cancer from the GeparQuinto Study

Journal of Clinical Oncology | Jun 02, 2018 Clinical Pharmacology

« Prev 1 … 88 89 90 91 92 … 106 Next »

In-utero exposure to metformin for type 2 diabetes or polycystic ovary syndrome: A prospective comparative observational study

Lymphocyte immunotherapy for recurrent miscarriages: Predictors of therapeutic success

Socioeconomic status and treatment of depression during pregnancy: A retrospective population-based cohort study in British Columbia, Canada

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal carcinomatosis: Systematic review of clinical and experimental evidence with special emphasis on ovarian cancer

Examining the association of antidepressant prescriptions with first abortion and first childbirth

Hormonal, metabolic, and endometrial safety of testosterone vaginal cream vs estrogens for the treatment of vulvovaginal atrophy in postmenopausal women: A randomized, placebo-controlled study

A phase II study of frontline paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus, or ixabepilone/carboplatin/bevacizumab in advanced/recurrent endometrial cancer

Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol. A secondary analysis from 3 RCTs

Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): A randomised phase 3 trial

BRCA1/2 mutations and bevacizumab in the neoadjuvant treatment of breast cancer: Response and prognosis results in patients with triple-negative breast cancer from the GeparQuinto Study

Optimising Caesarean Section Practices

New Treatment in Uveitis

Environmental Pollution and Lifestyle Disorders: An Emerging Global Challenge

Anaemia: Types and Management

The evolving landscape of CDK4/6i therapy in metastatic Breast Cancer: Experts discuss key findings and future directions

In-utero exposure to metformin for type 2 diabetes or polycystic ovary syndrome: A prospective comparative observational study

Lymphocyte immunotherapy for recurrent miscarriages: Predictors of therapeutic success

Socioeconomic status and treatment of depression during pregnancy: A retrospective population-based cohort study in British Columbia, Canada

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal carcinomatosis: Systematic review of clinical and experimental evidence with special emphasis on ovarian cancer

Examining the association of antidepressant prescriptions with first abortion and first childbirth

Hormonal, metabolic, and endometrial safety of testosterone vaginal cream vs estrogens for the treatment of vulvovaginal atrophy in postmenopausal women: A randomized, placebo-controlled study

A phase II study of frontline paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus, or ixabepilone/carboplatin/bevacizumab in advanced/recurrent endometrial cancer

Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol. A secondary analysis from 3 RCTs

Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): A randomised phase 3 trial

BRCA1/2 mutations and bevacizumab in the neoadjuvant treatment of breast cancer: Response and prognosis results in patients with triple-negative breast cancer from the GeparQuinto Study

Optimising Caesarean Section Practices

New Treatment in Uveitis

Environmental Pollution and Lifestyle Disorders: An Emerging Global Challenge

Anaemia: Types and Management

The evolving landscape of CDK4/6i therapy in metastatic Breast Cancer: Experts discuss key findings and future directions

Select Specialty

Select Topic